Rothschild & Co Upgrades CME Group to Buy, Raises Price Target to $323

سي إم إي إنك

CME Group Inc. Class A

CME

0.00

Rothschild & Co analyst Simon Clinch upgrades CME Group (NASDAQ: CME) from Neutral to Buy and raises the price target from $316 to $323.